Saturday 17 October 2026
Export NAKA’s income statement to Excel — free account
KindlyMD, Inc.
NAKA Financial Capital Markets
KindlyMD, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.8 million, down 33.0% from fiscal 2024. In the quarter to June 2026, revenue grew 8,680.7%, EPS grew 52.5% and free cash flow fell 25.7%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
7.13
0.96
−11.87%
Follow NAKA
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
— | 4 | 3 | 2 |
| (37.62%) | (20.21%) | (157.33%) | (342.78%) | ||
| (25.97%) | (14.23%) | (93.04%) | (194.52%) | ||
ROIC |
(2.05%) | (25.29%) | (61.16%) | (135.54%) | |
Return on Tangible Assets |
48.28% | (666.87%) | 154.01% | 276.64% | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(138.11) | (144.36) | (47.05) | (34.40) | |
Free Cash Flow |
(701.24) | (722.51) | (748.72) | (687.94) | |
Capital Expenditures |
(684.39) | (699.00) | (702.79) | (640.66) | |
| Other line items | |||||
Cash ROIC |
(139.76%) | (134.97%) | (186.08%) | (269.27%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
0.01 | 0.00 | 0.04 | 2.71 | |
Inventory Turnover |
0.00 | — | 0.00 | 0.00 | |
Average Days of Payables |
93,181.79 | 0.00 | 19,146.41 | 260.60 | |
Days of Inventory on Hand |
0.00 | — | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | (0.05) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
843.98% | 1,149.35% | 951.13% | 132.38% | |
Share Based Compensation of Revenue |
146.63% | 134.65% | 106.30% | 15.58% | |
Interest Coverage |
— | (28.21) | (28.77) | (30.82) | |
Operating CF/Net income |
0.19 | 0.45 | 0.16 | 0.11 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
(672.22) | (218.04) | (163.33) | (5.73) | |
Revenue per Share |
0.39 | 0.45 | 0.27 | 1.99 | |
Operating CF per Share |
(3.32) | (4.70) | (2.89) | (2.36) | |
Capex per Share |
(134.79) | (139.66) | (44.17) | (32.03) | |
Capex to Sales |
345.55 | 313.48 | 162.39 | 16.10 |
Columns are period end dates